Tuesday, April 14, 2026 | 04:10 PM ISTहिंदी में पढें
Glaxosmithkline Pharmaceuticals Ltd
Board Meeting Intimation for Audited Financial Results (Standalone & Consolidated) For The Year Ended 31St March 2023
05:18 PM, 3rd May 2023
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2023 inter alia to consider and approve Audited Financial Results (Standalone & Consolidated) for the year ended 31st March 2023 and to recommend dividend if any on the equity shares of the Company.